Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Sight Sciences reported March 13 that it generated 2022 total revenue of $71.3 million, an increase of 46 percent over $49.0 million in 2021. Surgical glaucoma revenue in 2022 was $65.6 million, an...
Shanghai-based AffaMed Technologies announced March 20 that the Taiwan Food and Drug Administration had approved the Mini Well, Mini Well Proxa, Mini Well Toric, and Mini 4 Ready intraocular lenses...
Investigators at Cedars-Sinai Medical Center in Los Angeles have analyzed changes in the retina and how they correspond to brain and cognitive changes in patients with Alzheimer’s disease. They say...
HCP Cureblindness, formerly known as the Himalayan Cataract Project, reported March 16 that it would immediately acquire the SightLife International Program, the global division of Seattle-based Si...
Sight Sciences announced March 9 that it had launched the Ergo-Series of its OMNI glaucoma surgical system in the US. It is expected to be available outside the US later this year, the company said...
Neurophth Therapeutics announced March 7 that a Maltese college student with ND1-associated Leber hereditary optic neuropathy (LHON) received treatment free of charge with the company’s investigati...
Cognition Therapeutics announced March 15 that the US FDA had cleared its investigational new drug (IND) application for a Phase II study of CT1812 for geographic atrophy (GA) secondary to dry age-...
Abeona Therapeutics, of New York and Cleveland, unveiled on March 14 three preclinical gene therapy product candidates from its ophthalmology program. Abeona says ABO-504 is designed to reconstitut...
An optimistic mood prevailed at the 38th congress of the Asia-Pacific Academy of Ophthalmology (APAO). It was not just because the meeting in Kuala Lumpur, Malaysia, was the first live meeting of t...
Ophthalmic manufacturer revenue in Q4-2022 totaled $10.8 billion. Three public companies reported above-average revenue in Q4-2022 compared with the past three years, while 11 public companies had ...
US ophthalmologists reported that ophthalmic procedures grew 0.3 percent in Q4-2022 compared with the same quarter in 2021, according to Market Scope’s latest survey. Year-over-year performance var...
The loss of Silicon Valley Bank (SVB) as a lender would be a big blow for small, innovative ophthalmic companies that carry too much risk for a big bank, according to Gil Kliman, MD, a retina-train...
Advancements in vitrectomy machine technology are expected to improve safety and efficacy and enable surgeons to reach a larger population of patients with retinal disease over the next five years....
Johnson & Johnson Vision stepped into the lenticular extraction market in Asia at the 2023 APAO Congress in Kuala Lumpur with the introduction of the company’s new Elita femtosecond laser system an...
The European Council voted unanimously March 7 to extend the transition period for medical devices under the Medical Devices Regulation (MDR) and to remove the sell-off provisions for existing prod...
Danish company Norlase announced Feb. 14 that its line of ophthalmic lasers had achieved EU MDR certification. Norlase markets the Leaf, a laser photocoagulator that mounts directly on a slit lamp;...
India-based Remidio announced Feb. 23 that it had received CE mark approval for its Medios AI, an algorithm that detects referable diabetic retinopathy (DR). The artificial intelligence system work...
Akorn Pharmaceuticals shut down all its US sites on Feb. 23 and laid off its workforce, after recent financial and regulatory struggles. In an email to employees dated Feb. 22, the Gurnee, Illinois...
The US FDA had two clearances through the ophthalmic device division using the 510(k) pathway in February 2023, according to the agency’s database. Phelcom Technologies gained market clearance for ...
Bausch + Lomb received premarket approval (PMA) from the US FDA on Feb. 22 for its StableVisc (1.0% sodium hyaluronate) ophthalmic viscosurgical device (OVD) in cataract surgery. Concurrently, the ...
Roche’s Genentech announced Feb. 10 that it had broken ground on a new biologics manufacturing facility at its Oceanside, California, campus, north of San Diego. The campus currently has seven buil...
The owners of Indian ophthalmic company Appasamy Associates plan to sell a controlling stake in the company and are in initial talks with private equity investors, The Economic Times of India repor...
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease. Company Location About NovelMed Therapeutics Cleveland, Ohio The company is developing NM308...
Swiss drugmaker Novartis is working with an adviser to sell off its portfolio of front-of-the-eye treatments, including dry eye drug Xiidra, Bloomberg News reported March 14. Xiidra generated $487 ...
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.